GlaxoSmithKline's Rotarix gets regulatory green light

Article

GlaxoSmithKline's vaccine, Rotarix, receives approval for use in children.

Treatments to prevent rotavirus-caused gastroenteritis will soon gain an addition now that a new vaccine has been approved by the Food & Drug Administration.

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

Recent Videos
Related Content
© 2025 MJH Life Sciences

All rights reserved.